Top

Published in:

Open Access 01-09-2018 | Commentary

Imaging before cardiac resynchronisation therapy implantation—luxury or necessity?

Authors: A. H. Maass, S. C. Yap

Published in: Netherlands Heart Journal | Issue 9/2018

Excerpt

Cardiac resynchronisation therapy (CRT) is increasingly being used to treat or prevent heart failure in patients with intraventricular or atrioventricular conduction delay. Due to improved implantation tools and improved electrode design, implantation failure rates have decreased in recent years from 5–10% to less than 4%, questioning the need for pre-implantation imaging [1]. The introduction of quadripolar leads in particular has led to reduction of implant failures and the need for reoperation due to left ventricular lead failure, as has been shown by randomised comparison of bipolar to quadripolar leads [1]. …

Boriani G, Connors S, Kalarus Z, Lemke B, et al. Cardiac resynchronization therapy with a quadripolar electrode lead decreases complications at 6 months: results of the MORE-CRT randomized trial. JACC Clin Electrophysiol. 2016;2:212–20.CrossRefPubMed

Nguyên UC, Cluitmans MJM, Luermans JGLM, et al. Visualisation of coronary venous anatomy by computed tomography angiography prior to cardiac resynchronisation therapy implantation. Neth Heart J. 2018; https://doi.org/10.1007/s12471-018-1132-2.PubMedCrossRefPubMedCentral

Mischke K, Knackstedt C, Muhlenbruch G, et al. Imaging of the coronary venous system: retrograde coronary sinus angiography versus venous phase coronary angiograms. Int J Cardiol. 2007;119:339–43.CrossRefPubMed

Wang YJ, Liu L, Zhang MC, et al. Imaging of pericardiophrenic bundles using multislice spiral computed tomography for phrenic nerve anatomy. J Cardiovasc Electrophysiol. 2016;27:961–71.CrossRefPubMed

Khan FZ, Virdee MS, Palmer CR, et al. Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial. J Am Coll Cardiol. 2012;59:1509–18.CrossRefPubMed

Saba S, Marek J, Schwartzman D, et al. Echocardiography-guided left ventricular lead placement for cardiac resynchronization therapy: results of the Speckle Tracking Assisted Resynchronization Therapy for Electrode Region trial. Circ Heart Fail. 2013;6:427–34.CrossRefPubMed

Behar JM, Mountney P, Toth D, et al. Real-time X‑MRI-guided left ventricular lead implantation for targeted delivery of cardiac resynchronization therapy. JACC Clin Electrophysiol. 2017;3:803–14.CrossRefPubMed

Morgan JM, Biffi M, Geller L, et al. ALternate Site Cardiac ResYNChronization (ALSYNC): a prospective and multicentre study of left ventricular endocardial pacing for cardiac resynchronization therapy. Eur Heart J. 2016;37:2118–27.CrossRefPubMed

Schouwenburg JJ, Klinkenberg TJ, Maass AH, Mariani MA. Video-assisted thoracic placement of epicardial leads. J Card Surg. 2014;29:286–9.CrossRefPubMed

10.

Maass AH, Vernooy K, Wijers SC, et al. Refining success of cardiac resynchronization therapy using a simple score predicting the amount of reverse ventricular remodelling: results from the Markers and Response to CRT (MARC) study. Europace. 2018;20:e1–e10.CrossRefPubMed

11.

Mullens W, Grimm RA, Verga T, et al. Insights from a cardiac resynchronization optimization clinic as part of a heart failure disease management program. J Am Coll Cardiol. 2009;53:765–73.CrossRefPubMed

12.

Kloosterman M, Rienstra M, Mulder BA, et al. Atrial reverse remodelling is associated with outcome of cardiac resynchronization therapy. Europace. 2016;18:1211–9.CrossRefPubMed

Title: Imaging before cardiac resynchronisation therapy implantation—luxury or necessity?
Authors: A. H. Maass
S. C. Yap
Publication date: 01-09-2018
Publisher: Bohn Stafleu van Loghum
Published in: Netherlands Heart Journal / Issue 9/2018
Print ISSN: 1568-5888
Electronic ISSN: 1876-6250
DOI: https://doi.org/10.1007/s12471-018-1140-2

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The STEP trials

Springer Medicine

Imaging before cardiac resynchronisation therapy implantation—luxury or necessity?

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 9/2018

Trends in TAVI

Short versus conventional hydration for prevention of kidney injury during pre-TAVI computed tomography angiography

A peek behind the curtain

Visualisation of coronary venous anatomy by computed tomography angiography prior to cardiac resynchronisation therapy implantation

Red blood cell transfusion in patients with ST-elevation myocardial infarction—a meta-analysis of more than 21,000 patients

Einthoven dissertation prizes 2017

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page